Human papillomavirus vaccination coverage among young, gay, bisexual, and other men who have sex with men and transgender women — 3 U.S. cities, 2016–2018

Figures & data

Table 1. HPV vaccination coverage* among participating gay, bisexual, and other men who have sex with men, by participant characteristics – 3 U.S. cities, 2016–2018

Characteristic	Overall N (column %)	Vaccinated against HPV* n (row %)	P value
Total	1416 (100.0)	673 (47.5)
City			<.01
Chicago	525 (37.1)	229 (43.6)
Seattle	518 (36.6)	322 (62.2)
Los Angeles	373 (26.3)	122 (32.7)
Age, years			<.01
18–21	490 (34.6)	262 (53.5)
22–26	926 (65.4)	411 (44.4)
Race/ethnicity			<.01
White, NH	444 (31.4)	259 (58.3)
Hispanic/Latino	426 (30.1)	193 (45.3)
Black/African American, NH	221 (15.6)	70 (31.7)
Asian, Native Hawaiian/Pacific Islander, NH	107 (7.6)	64 (59.8)
Multiple race/ethnicity, NH	106 (7.5)	51 (48.1)
Other race/ethnicity**	112 (7.9)	36 (32.1)
Gender identity			.01
Male	1342 (94.8)	640 (47.7)
Female/transgender female	39 (2.8)	11 (28.2)
Other or unknown gender identity	35 (2.5)	22 (62.9)
Sexual orientation			.20
Gay	1014 (71.6)	486 (47.9)
Bisexual, queer, or other sexual orientation	298 (21.1)	131 (44.0)
Straight, unsure, or unknown sexual orientation	104 (7.3)	56 (53.9)
Self-reported HIV status			.22
HIV-positive	113 (8.0)	60 (53.1)
HIV-negative or unknown HIV status	1303 (92.0)	613 (47.1)

Abbreviations: HPV, human papillomavirus; NH, non-Hispanic/Latino; PrEP, pre-exposure prophylaxis; HIV, human immunodeficiency virus.

*Self-reported receiving ≥1 dose of HPV vaccine at age ≥9 years.

**Includes American Indian/Alaska Native, NH; other race/ethnicity; unknown race/ethnicity.

Table 2. HPV vaccination coverage* among participating gay, bisexual, and other men who have sex with men, by city and participant characteristics – 3 U.S. cities, 2016–2018

	Vaccinated against HPV
	Chicago			Seattle			Los Angeles
Characteristic	N	n (%)	P value	N	n (%)	P value	N	n (%)	P value
All participants	525	229 (43.6)		518	322 (62.2)		373	122 (32.7)
Age, years			.01			.01			.08
18–21	296	144 (48.7)		124	89 (71.8)		70	29 (41.4)
22–26	229	85 (37.1)		394	233 (59.1)		303	93 (30.7)
Race/ethnicity			<.01			.95			.25
White, NH	139	82 (59.0)		266	164 (61.7)		39	13 (33.3)
Hispanic/Latino	151	65 (43.1)		103	67 (65.1)		172	61 (35.5)
Black/African American, NH	181	53 (29.3)		31	17 (54.8)		9	-
Asian, Native Hawaiian/Pacific Islander, NH	13	6 (46.2)		93	58 (62.4)		<5	-
Multiple race/ethnicity, NH	30	20 (66.7)		16	10 (62.5)		60	21 (35.0)
Other race/ethnicity**	11	3 (27.3)		9	6 (66.7)		92	27 (29.4)
Gender identity			.02			.28			.02
Male	480	205 (42.7)		504	316 (62.7)		358	119 (33.2)
Female/transgender female	26	10 (38.5)		<5	-		10	-
Other or unknown gender identity	19	14 (73.7)		11	5 (45.5)		5	-

Where >20% of cells had expected counts <5, Fisher’s exact test was used; other results are from chi-square test. Cell counts <5 were suppressed to protect participant privacy. Abbreviations: HPV, human papillomavirus; NH, non-Hispanic/Latino; STD, sexually transmitted disease; IQR: interquartile range.

*Self-reported receiving ≥1 dose of HPV vaccine at age ≥9 years.

**Includes American Indian/Alaska Native, NH; other race/ethnicity; unknown race/ethnicity.

Table 3. Characteristics of participating gay, bisexual, and other men who have sex with men who reported receiving ≥1 dose of HPV vaccine* overall and by city – 3 U.S. cities, 2016–2018

Characteristic	Overall N (%) or median (IQR)	Chicago n (%) or median (IQR)	Seattle n (%) or median (IQR)	Los Angeles n (%) or median (IQR)
Total	673	229	322	122
Age at first dose of HPV vaccine, years	19 (16, 22)	17 (15, 20)	21 (18, 23)	19.5 (16, 22)
Age at first sex, years	17 (15, 18)	16 (15, 17)	17 (15, 18)	17 (15, 18)
Age at first dose of HPV vaccine relative to age at first sex**
Age at first dose < age at first sex	139 (20.7)	69 (30.1)	39 (12.1)	31 (25.4)
Age at first dose ≥ age at first sex	533 (79.2)	159 (69.4)	283 (87.9)	91 (74.6)
Location for first dose of HPV vaccine
Public health/STD clinic	225 (33.4)	45 (19.7)	158 (49.1)	22 (18.0)
Pediatrician’s office	185 (27.5)	107 (46.7)	44 (13.7)	34 (27.9)
Family/internal medicine clinic	182 (27.0)	56 (24.5)	81 (25.2)	45 (36.9)
Other location***	81 (12.0)	21 (9.2)	39 (12.1)	21 (17.2)

Abbreviations: HPV, human papillomavirus; STD, sexually transmitted disease; IQR: interquartile range *Eligible age for HPV vaccine was age ≥9 years.

**Numbers may not add to total due to missing data.

***Other, hospital or emergency room, pharmacy, unknown.